Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Epithelial cell polarity and improved early outcomes in delayed graft function: a pilot study of polyclonal vs monoclonal antibodies.
Movement Advocacy, Personal Relationships, and Ending Health Care Disparities.
Reframing the Value of Treatments for Relapsed/Refractory Multiple Myeloma.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Reframing the Value of Treatments for Relapsed/Refractory Multiple Myeloma.
Reframing the Value of Treatments for Relapsed/Refractory Multiple Myeloma. J Manag Care Spec Pharm. 2018 07; 24(7):711-712.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Cost-Benefit Analysis
Humans
Multiple Myeloma
United States
authors with profiles
Andrzej Jakubowiak